Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirofiban After PCI in Non-Emergency Coronary Complex High-Risk Patients
ChiCTR2500095812Phase 4Not yet recruiting
- Sponsor
- Tongji Hospital
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tirofiban in coronary arteriosclerosis (2 arms), sponsored by Tongji Hospital. Primary endpoints: Ischemic Events and Bleeding Events. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
tirofiban
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR2500095812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500095812.